• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Innovative Eyewear Inc. Reports First Quarter 2024 Financial Results

    5/14/24 8:30:00 AM ET
    $LUCY
    Ophthalmic Goods
    Health Care
    Get the next $LUCY alert in real time by email

    Units sold increased 150% & Revenue Increased 165% in Q1 2024 vs Q1 2023

    MIAMI, May 14, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW))), a developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the first quarter of 2024.

    Lucyd Glasses
Photo courtesy of Innovative Eyewear Inc.

    Net revenue for the quarter ended March 31, 2024 was $383,471, an increase of 165% from the quarter ended March 31, 2023. This year-over-year increase was primarily attributable to significant volume growth in the e-commerce channel, driven by the Company's strategic advertising and marketing initiatives during the latter portion of 2023 and through the current quarter, combined with recent new product launches (including the Lyte XL and Nautica® Powered by Lucyd collections).

    Future Outlook

    The sales growth reported by the Company precedes the launch of three new product lines - Eddie Bauer® Powered by Lucyd, Reebok® Powered by Lucyd, and the Lucyd Armor smart safety glasses line - all of which we are bullish about as they are expected to present additional revenue generating opportunities for us in 2024. In addition, the Company plans to launch new features for the Lucyd app in 2024, including a paid "Pro" version of the app, which will provide another potential incremental revenue stream for the Company from glasses customers.

    While the Company has started to realize some economies of scale in the cost of frames and in the area of shipping and logistics, the cost of prescription lenses has grown disproportionately and significantly more than the Company's revenue, which has had a significant negative impact on gross profit margin. Prescription smart eyewear offered direct-to-consumer has been a key unique selling point used to attract new customers, bringing an important marketing benefit since it is not offered by most of our competitors. We are working with our current prescription lens provider to explore opportunities to reduce costs and we are also actively in discussions with alternative prescription lens suppliers whom we believe may help further lower our lens fulfillment costs. Ultimately, we believe that the majority of our business will come from frame sales to distributors and eyewear retailers, who will outfit lenses themselves for the final customer. We anticipate that the launches of more co-branded products later this year will help us progress towards our long-term goal of shifting our sales mix over time more towards the wholesale channel, which carries higher margins for us as such sales to our third-party retail store partners do not include the cost of prescription lenses.

    Finally, as we continue to refine our product mix with sales data, we anticipate further reducing our unit costs by focusing only on the highest volume, market-tested styles.

    Harrison Gross, CEO of Innovative Eyewear Inc., commented,

    "Our most recent quarter marked the third sequential quarter of year-over-year revenue growth. I am pleased by our continued growth and excited by the potential of further growth later this year with the upcoming launches of new product lines and upgraded app releases.

    This is an exciting time for the Company. After several years of rigorous R&D and brand development, I believe we are very well-positioned to capitalize on blooming consumer interest in smart eyewear. Recently, we have seen powerful incumbents such as Apple and Meta bringing renewed interest to smart glasses, which helps us quite directly by raising consumer awareness for the category. We believe this has enhanced investor and consumer confidence in the category. As the value leader in prescription smart eyewear, we are a practical alternative to the Apple Vision Pro and Meta Glasses for consumers seeking a lightweight, AI-enabled and affordable option for all-day wear. The fact that our products are available in dozens of different styles, with thousands of frame and custom lens combinations, provides consumers with the necessary optionality that they expect when making an eyewear selection. We continue to expect that smart eyewear will be a key component of the generative AI revolution, due to their transparent interfaces and ergonomic form factors perfectly suited for voice-based interaction."

    Forward Looking Statements

    This press release contains certain forward-looking statements, including those relating to the Company's business operations, projections, market position, future product lines and developments. Forward-looking statements are based on the Company's current expectations and assumptions. The Private Securities Litigation Reform Act of 1995 provides a safe-harbor for forward-looking statements. These statements may be identified by the use of forward-looking expressions, including, but not limited to, "anticipate," "believe," "continue," "estimate," "expect," "future," "intend," "may," "outlook," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in the Company's filings with the Securities and Exchange Commission, including its annual report on Form 10-K under the caption "Risk Factors."

    Investor Relations Contacts:

    Innovative Eyewear Inc.

    Scott Powell

    Skyline Corporate Communications Group, LLC

    Office: +1 (646) 893-5835

    Email: [email protected]

    Innovative Eyewear (PRNewsfoto/Innovative Eyewear)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/innovative-eyewear-inc-reports-first-quarter-2024-financial-results-302144877.html

    SOURCE Innovative Eyewear, Inc.

    Get the next $LUCY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LUCY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LUCY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Innovative Eyewear Inc. Reports Q1 2025 Unaudited Financial Results

      Revenue and gross margins improvements MIAMI, May 13, 2025 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its Q1 2025 Unaudited financial results. Net revenue for the quarter ended March 31, 2025 was $454,501 an increase of 19% from revenue of $383,471 in the quarter ended March 31, 2024. This increase was primarily attributable to growth in unit sales volume, largely driven by product launches during 2024 of the co-branded Nautica® Powered by Lucyd and

      5/13/25 5:49:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear Partners with Eye Recommend, Expanding Smart Eyewear Access Across 600+ Independent Optometry Stores

      MIAMI, May 5, 2025 /PRNewswire/ -- Innovative Eyewear, Inc. (NASDAQ:LUCY, LUCYW)), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announces that it has partnered with Eye Recommend to provide its smart eyewear to more than 600 independent optical practices across Canada, significantly broadening accessibility of Innovative Eyewear's smart eyewear throughout the Canadian market. Buying groups like Eye Recommend serve an important function in the optical industry landscape, making it easier for independent optometrists to access

      5/5/25 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear Launches Reebok® Smart Eyewear

      MIAMI, April 28, 2025 /PRNewswire/ -- Innovative Eyewear Inc. (NASDAQ:LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the launch of Reebok Smart Eyewear, available worldwide on Lucyd.co. Expanded availability is expected later this quarter on Reebok.com and select online and traditional retailers. A Landmark Product Launch The global smart glasses market is projected to reach approximately $13 billion worldwide by 20301. We believe Reebok Powered by Lucyd smart eyewear positions Innovative Eyewear at the forefr

      4/28/25 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Innovative Eyewear Inc.

      10-Q - Innovative Eyewear Inc (0001808377) (Filer)

      5/13/25 4:30:26 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • SEC Form S-1 filed by Innovative Eyewear Inc.

      S-1 - Innovative Eyewear Inc (0001808377) (Filer)

      5/9/25 4:05:44 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • SEC Form SCHEDULE 13G filed by Innovative Eyewear Inc.

      SCHEDULE 13G - Innovative Eyewear Inc (0001808377) (Subject)

      4/17/25 4:04:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Innovative Eyewear Inc.

      SC 13G/A - Innovative Eyewear Inc (0001808377) (Subject)

      11/13/24 11:18:48 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

      SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

      10/4/24 4:43:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: SEC Form SC 13D/A filed by Innovative Eyewear Inc.

      SC 13D/A - Innovative Eyewear Inc (0001808377) (Subject)

      9/25/24 4:17:38 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 4:12:34 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 2:41:40 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $2,649,148 worth of shares (297,443 units at $8.91) and sold $384,100 worth of shares (42,328 units at $9.07) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 2:40:55 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Leadership Updates

    Live Leadership Updates

    See more
    • Innovative Eyewear, Inc. Signs Professional Football Player Emmanuel Ogbah as Brand Ambassador

      MIAMI, Dec. 14, 2023 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW))), the developer of the developer of ChatGPT smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased to announce the signing of Emmanuel Ogbah as an official brand ambassador. Emmanuel Ikechukwu Ogbah is a Nigerian professional football defensive end for the Miami Dolphins. He played college football at Oklahoma State and was drafted by the Cleveland Browns in the second round of the 2016 NFL Draft. Lucyd eyewear's open-ear au

      12/14/23 8:30:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Financials

    Live finance-specific insights

    See more
    • Innovative Eyewear Inc. Reports Third Quarter 2024 Financial Results

      Revenue Increased 14% in Q3 2024 vs Q3 2023, and 76% on a Year-to-Date Basis vs 2023 MIAMI, Nov. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW)), a developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the third quarter of 2024. Net revenue for the quarter ended September 30, 2024 was $253,599, an increase of 14% from the quarter ended September 30, 2023. This year-over-year increase was primarily attributable to strategic reductions in price discounts and other adjustments to o

      11/13/24 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear, Inc. Adopts Limited Duration Stockholders Rights Plan

      MIAMI, Sept. 25, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced that its Board of Directors has approved the adoption of a limited duration stockholder rights plan (the "Rights Plan") and declared a dividend distribution of one right ("Right") for each outstanding share of common stock. The record date for such dividend distribution is September 25, 2024. The Rights Plan expires, without any further action being required to be taken by Innovative Eyewear's Board of Directors, on September 25, 2025 or at such earlier time as disclos

      9/25/24 8:20:00 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Innovative Eyewear Inc. Reports Second Quarter 2024 Financial Results

      Quarterly Revenue Increased 82% vs Q2 2023; Gross Margin Increases Substantially MIAMI, Aug. 13, 2024 /PRNewswire/ -- Innovative Eyewear Inc., (NASDAQ:LUCY, LUCYW))), the developer of ChatGPT-enabled smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced its financial results for the second quarter of 2024. Net revenue for the quarter ended June 30, 2024 was $308,682, an increase of 82% from the quarter ended June 30, 2023. Net revenue for the six months ended June 30, 2024 was $692,153, an increase of 120% vs. the comparable period in 2023.

      8/13/24 8:00:00 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care

    $LUCY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Gayle Oswald

      3 - Innovative Eyewear Inc (0001808377) (Issuer)

      10/25/24 9:59:55 AM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $721,472 worth of shares (70,000 units at $10.31) and sold $148,896 worth of shares (14,037 units at $10.61) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 4:12:34 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care
    • Amendment: Large owner Galkin Vladimir bought $1,822,973 worth of shares (200,792 units at $9.08) (SEC Form 4)

      4/A - Innovative Eyewear Inc (0001808377) (Issuer)

      9/27/24 2:41:40 PM ET
      $LUCY
      Ophthalmic Goods
      Health Care